Project Details
Description
Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect (ASCENT ASD Study)secundum atrial septal defect
| Status | Active |
|---|---|
| Effective start/end date | 9/6/23 → 9/30/33 |
Funding
- ATHEART MEDICAL
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.